The stock market finished Tuesday’s trading on a positive note with all major indices ending in the green, buoyed by the influx of corporate earnings results.
The Dow Jones grew by 0.75 percent, the S&P 500 rose by 0.58 percent, and the Nasdaq was up by 0.55 percent.
Ten companies mirrored the broader market optimism, leading the charge with strong gains, predominantly driven by impressive earnings results.
In this article, let us explore Tuesday’s 10 top-performing stocks and the reasons behind their gains.
To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5-million trading volume.
A man in long sleeves looking at stock market data. Photo by Tima Miroshnichenko on Pexels
10. Deutsche Bank Aktiengesellschaft (NYSE:DB)
Shares of Deutsche Bank rallied for a third consecutive day on Tuesday, adding 4.06 percent to close at $26.78 apiece as investors cheered the company’s strong earnings performance for the first three months of the year.
In its earnings release, net income attributable to shareholders rose by 39 percent to €1.775 billion from €1.275 billion in the same period a year earlier.
Meanwhile, net revenues increased by 9.25 percent to €8.5 billion from €7.78 billion year-on-year, with revenues from investment banking operations contributing the largest chunk with €3.4 billion, followed by private banks with €2.4 billion, corporate banks with €1.9 billion, and asset management at €730 million.
According to Deutsche Bank Aktiengesellschaft (NYSE:DB) CEO Christian Sewing, the strong performance put the company “on track for delivery on all our 2025 targets,” underscoring that the first quarter marked “our best quarterly profit for fourteen years.”
9. Peloton Interactive Inc. (NASDAQ:PTON)
Peloton Interactive grew its share prices by 5 percent on Tuesday, a sixth straight day, to end at $6.93 apiece as investor sentiment was boosted by an investment firm’s rating upgrade for the company.
On Monday, Truist Securities upgraded its rating for Peloton Interactive Inc. (NASDAQ:PTON) to Buy from Hold previously, while giving it a price target of $11, or a 59-percent upside from its latest closing price.
Truist said the upgrade was based on its improving fundamentals, cleaner balance sheet, and a clearer path to sustained profitability under new leadership, and that its efforts to reduce operating expenses and stabilize cash flow are starting to bear fruit.
Meanwhile, Peloton Interactive, Inc. (NASDAQ:PTON) will release its key financial and operational highlights before the market opens on Thursday, May 8, 2025, where investors will be looking out for any cues on the company’s outlook for the next quarter and the rest of the year amid the growing global economic uncertainties.
8. Archer Aviation Inc. (NYSE:ACHR)
Archer Aviation grew its share prices by 5.39 percent on Tuesday to finish at $8.99 apiece as investors snapped up shares ahead of the release of its first quarter earnings performance, supported by the progress in its air taxis launch in Abu Dhabi.
According to the company, it is scheduled to release its earnings results after market close on Monday, May 12, 2025.
In recent news, the UAE General Civil Aviation Authority approved the design of the first hybrid heliport to be located at the Abu Dhabi Cruise Terminal at Zayed Port, a leading hub for the regional cruise industry that welcomes more than 650,000 visitors annually. The approval paved the way for the looming takeoff of Archer Aviation Inc.’s (NYSE:ACHR) commercial air taxis.
The new heliport was designed in partnership with ACHR, AD Ports Group, and Falcon Aviation Services, and will accommodate both traditional helicopters and electric vertical take-off and landing (eVTOL) aircraft.
7. Honeywell International Inc. (NASDAQ:HON)
Honeywell rallied by 5.40 percent on Tuesday to finish at $211.49 apiece as investor sentiment was buoyed by its strong earnings performance and estimates beat in the first quarter of the year.
Despite net income ending slightly lower, down 0.5 percent to $1.467 billion versus $1.475 billion in the same period last year, revenues managed to jump by 7.87 percent to $9.822 billion from $9.105 billion year-on-year.
Additionally, Honeywell International Inc. (NASDAQ:HON) posted adjusted earnings per share of $2.51, beating analyst estimates of $2.19 by 14.6 percent. This marked the fourth consecutive quarter of beating analyst consensus.
Looking ahead, Honeywell International Inc. (NASDAQ:HON) also updated its full-year 2025 outlook, with sales now pegged at between $39.6 billion and $40.5 billion or growth of 2 to 5 percent year-on-year.
Adjusted EPS is expected to settle anywhere between $10.20 and $10.50 apiece.
6. Verona Pharma PLC (NASDAQ:VRNA)
Verona Pharma extended its rally for an eighth straight day on Tuesday, adding 6.37 percent to end at $73.21 apiece after the company posted an impressive earnings performance during the first three months of the year.
In its earnings release, Verona Pharma PLC (NASDAQ:VRNA) said that it narrowed its net loss by 36.8 percent to $16.3 million from $25.79 million in the same period a year earlier.
Net revenues stood at $76.3 million, primarily driven by $71.3 million in net sales from Ohtuvayre, the company’s maintenance treatment of COPD.
In February this year, Verona Pharma PLC (NASDAQ:VRNA), through its partner Nuance Pharma, secured the green light of the Macau government to sell Ohtuvayre in the special administrative region.
Commenting on its strong performance, VRNA President and CEO David Zaccardelli said: “We are extremely pleased to report that for the first time, Verona’s quarterly revenue exceeded our operating expenses, excluding non-cash charges. We believe we are in a robust financial position to continue commercializing Ohtuvayre, advance our clinical pipeline, and implement our global strategy.”
5. Noble Corporation PLC (NYSE:NE)
Noble Corporation saw its share prices pick up by 7 percent on Tuesday to finish at $22.47 apiece following the company’s strong earnings performance in the first quarter of the year.
On Monday, Noble Corporation PLC (NYSE:NE) said net income in the first three months rose by 13.68 percent to $108 million from $95 million in the same period a year earlier, as revenues jumped by 37 percent to $874 million from $637 million year-on-year.
Further adding to the sentiment was the company’s newly secured contracts that raised its total backlog to $7.5 billion, enhancing the company’s future revenue potential.
In its fleet status report, Noble Corporation PLC (NYSE:NE) said that two of its drill ships won a contract for four years each with supermajor Shell in the US Gulf of Mexico. The contract also includes four one-year extension options per rig at mutually agreed rates.
The deals are set to begin in the middle of 2026 and the fourth quarter of 2027.
4. Okta Inc. (NASDAQ:OKTA)
Okta Inc. extended its winning streak for a sixth straight day on Tuesday, adding 7.4 percent to end at $112.54 apiece as investors cheered news that the company will be included in the S&P MidCap 400 before trading starts on Thursday, May 1.
The company replaced Berry Global Group, a plastic packaging manufacturing company that is set to be acquired by Amcor by the middle of the year. The merger will effectively remove Berry from the index.
While its inclusion in the index does not have any impact on the company’s key financial and operating results, Okta Inc.’s (NASDAQ:OKTA) addition means greater visibility for the company.
In recent news, the company announced the new Okta Platform, which aims to bring a unified, end-to-end identity security fabric to organizations for managing and securing all types of identities across their ecosystem, from AI agents to API keys to employees.
3. Clarivate PLC (NYSE:CLVT)
Clarivate saw its share prices jump by 17.27 percent on Tuesday to end at $4.21 apiece as investor sentiment was buoyed by the company’s maintained outlook for the full year despite posting dismal earnings performance in the first quarter.
In its latest earnings release, Clarivate PLC (NYSE:CLVT) said that it was maintaining its full-year outlook of between $2.28 billion and $2.4 billion in revenues, with adjusted EBITDA of $940 million to $1 billion.
In contrast, the company widened its net loss in the first quarter of the year by 38.5 percent to $103.9 million from $75 million year-on-year, as revenues dropped by 4.4 percent to $593.7 million from $621.2 million.
Total revenues decreased primarily due to inorganic divestitures, disposals, and foreign currency translation impacts. Organic revenues, on the other hand, increased by 0.3 percent.
2. Hesai Group (NASDAQ:HSAI)
Hesai Group extended its winning streak for a seventh straight day on Tuesday, jumping 18.49 percent to end at $18.20 apiece, followed by new lidar technology launches coupled with announcements that it would ramp up its production capacity fourfold this year.
Last week, Hesai Group (NASDAQ:HSAI) founder and CEO David Li Yifan said that the company will expand its manufacturing capacity to 2 million units this year from 502,000 units last year to keep up with the strong demand for its products used in driver-assistance systems in cars.
“We can guarantee capacity expansion to 2 million units within a few months,” he was quoted as saying at a media briefing. “Supply chain will not be an issue. For us, it is just a matter of building more facilities.”
In other news, Hesai Group (NASDAQ:HSAI) recently launched the Infinity Eye, a lidar solution for level 2 to 4 autonomous driving.
According to the company, the new technology includes three configurations—Infinity Eye A, B, and C—each tailored to meet the specific requirements of L4+ high-level autonomous systems, L3 conditional autonomous driving, and L2 assisted driving, respectively.
1. Hims & Hers Health, Inc. (NYSE:HIMS)
Hims & Hers soared by 23.03 percent on Tuesday to end at $35.04 apiece as investors cheered news that it partnered with Novo Nordisk for a long-term collaboration to market blockbuster weight loss medicine Wegovy.
In a statement, Hims & Hers Health, Inc. (NYSE:HIMS) said that Americans can now access NovoCare Pharmacy directly through the Hims & Hers platform, with a bundled offering of all dose strengths of Wegovy and a Hims & Hers membership, which includes access to 24/7 care, ongoing clinical support, and nutrition guidance, all in one place.
The companies are also working on the development of a roadmap that combines Novo Nordisk’s innovative treatments with Hims & Hers Health, Inc.’s (NYSE:HIMS) ability to scale access to quality care, aiming to improve long-term outcomes for more people, more affordably.
It can be learned that HIMS has been making a compounded knock-off version of the treatment that helped propel its sales over the past few years, but was later discontinued after the Food and Drug Administration announced that the treatment was already back in sufficient supply.
While we acknowledge the potential of HIMS as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than HIMS but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
Hedge Fund Resource Center